Identifying genetic mutations is crucial for understanding the molecular mechanisms of cancer. This knowledge can aid in the development of targeted therapies, improve diagnosis, and help predict patient prognosis. For example, the identification of the BRCA1 and BRCA2 mutations has led to better management of breast and ovarian cancers.
